These cell lines which are positive for estrogen receptor (ER), progesterone receptor (PR) and C-erbB-2, could provide us with new experimental materials to study the pathogenic mechanism and to screen for new therapeutic reagents against breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.